Safety, Efficacy of Vadadustat Explored for CKD

THURSDAY, April 29, 2021 -- Vadadustat met the noninferiority criteria for cardiovascular safety versus darbepoetin alfa among patients with dialysis-dependent chronic kidney disease (DD-CKD), but not those with non-DD-CKD (NDD-CKD), according to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news